期刊文献+

体外模拟乳腺脂肪微环境中过表达BMP9对乳腺癌细胞增殖和迁移的影响及其机制探讨 被引量:1

Effects of BMP9 over-expression on proliferation and migration of human breast cancer MDA-MB-231 cells in simulated breast adipose microenvironment in vitro and its possible mechanism
原文传递
导出
摘要 目的 :采用体外共培养技术模拟乳腺脂肪微环境,研究人骨形态发生蛋白9(bone morphogenetic protein9,BMP9)对人乳腺癌MDA-MB-231细胞增殖和迁移的影响,并初步探讨其可能的机制。方法 :将重组腺病毒Ad-BMP9(以Ad-GFP作为对照)导入MDA-MB-231细胞中,构建MDA-MB-231/Ad-BMP9重组细胞,再与前体脂肪细胞3T3-L1在Transwell共培养体系中间接共培养3 d。荧光显微镜下观察共培养体系中重组腺病毒Ad-BMP9在MDA-MB-231细胞中的感染效率,并通过RT-PCR和蛋白质印迹法验证BMP9在共培养体系的MDA-MB-231细胞中成功过表达。然后,分别采用MTT法、FCM法、划痕愈合实验和Transwell迁移实验检测MDA-MB-231细胞增殖和迁移能力的变化;蛋白质印迹法检测共培养的2种细胞中增殖和转移相关因子瘦素(leptin)的表达水平变化;细胞免疫荧光法和蛋白质印迹法分别检测MDA-MB-231细胞中leptin受体OB-R及leptin信号通路关键分子的表达水平变化。结果 :荧光显微镜下观察到重组腺病毒Ad-BMP9在共培养体系的MDA-MB-231细胞中感染效率为70%左右,且BMP9在共培养体系的MDA-MB-231细胞中成功过表达(P<0.05)。在模拟乳腺脂肪微环境的共培养体系中过表达BMP9后,乳腺癌MDA-MB-231细胞的增殖和迁移受到明显抑制(P<0.05),并且细胞周期阻滞于G2/M期(P<0.001)。过表达BMP9后,前体脂肪细胞3T3-L1中leptin表达显著下调(P<0.05),而MDA-MB-231细胞中磷酸化的STAT3(phosphorylated STAT3,p-STAT3)和磷酸化的ERK1/2(phosphorylated ERK1/2,p-ERK1/2)水平均明显下调(均P<0.05)。结论 :模拟乳腺脂肪微环境的共培养体系中,BMP9过表达可以调节乳腺癌细胞与前体脂肪细胞的相互作用,抑制乳腺癌MDA-MB-231细胞的增殖和迁移,且该抑制作用可能与leptin经典信号通路有关。 Objective: To investigate the effects of human bone morphogenetic protein 9 (BMP9) on proliferation and migration of human breast cancer MDA-MB-231 cells in simulated breast adipose microenvironment by co-culture technique, and to explore its possible mechanism. Methods: MDA- MB-231 cells were infected with recombinant adenovirus Ad-BMP9 or Ad-GFP (as the control), and then they were indirectly co-cultured with adipose progenitor 3T3-L1 cells for 3 days. The infection efficiency of recombinant adenovirus Ad-BMP9 in MDA-MB-231 cells in the co-culture system was observed under a fluorescence microscope, and the expression level of BMP9 was detected by reverse transcription (RT)-PCR and Western blotting. The effects of BMP9 overexpression on proliferation and migration of MDA-MB-231 cells were investigated by MTT method, flow cytometry, wound-healing assay and Transwell migration assay, respectively. The expression of proliferation and metastasis-related factor leptin in the cells in co-culture system was detected by Western blotting. The expressions of leptin receptor (OB-R) and the key molecules of leptin signaling pathway in MDA-MB-231 cells were detected by immunofluorescence staining and Western blotting. Results: The infection efficiency of recombinant adenovirus Ad-BMP9 in MDA-MB-231 cells in co-culture system was about 70% under a fluorescence microscope. The over- expression of BMP9 was successfully detected in MDA-MB-231 cells in co-culture system (P 〈 0.05). In co-culture system of simulated breast adipose microenvironment, BMP9 overexpression could significantly inhibit the proliferation (P 〈 0.05) and migration (P 〈 0.05) of MDA-MB-231 cells, and arrest the cell cycle at G2/M phase (P 〈 0.001). Compared with the control group, BMP9 overexpression could decrease the expession level of leptin in 3T3-L1 cells (P 〈 0.05), and down-regulate the expression levels of phosphorylated STAT3 (p-STAT3) (P 〈 0.05) and phosphorylated ERK1/2 (p-ERK1/2) (P 〈 0.05). Conclusion: BMP9 can inhibit the proliferation and migration of breast cancer MDA-MB-231 cells in simulated breast microenvironment by regulating the cross-talk between MDA-MB-231 cells and adipose progenitor 3T3-L1 cells. Leptin signaling pathway may be involved in this process.
出处 《肿瘤》 CAS CSCD 北大核心 2014年第9期781-789,共9页 Tumor
基金 国家自然科学基金资助项目(编号:81172017) 国家重点基础研究发展计划项目(编号:2011CB707906)
关键词 乳腺肿瘤 骨形态发生蛋白质类 脂细胞 细胞增殖 细胞迁移分析 Breast neoplasms Bone morphogenetic proteins Adipocytes Cell proliferation Cell migration assays
  • 相关文献

参考文献28

  • 1Paget S. The distribution of secondary growthsin cancer of the breast[J]. Cancer Metastasis Rev,1989,8(2):98-101.
  • 2Tan J, Buache E, Chenard MP, et al. Adipocyte isa non-trivial, dynamic partner of breast cancercells[J]. IntJ DeveBioIt 2011,55(7-9):851-859.
  • 3Nieman KM, Romero IL, Van Houten B, et al.Adipose tissue and adipocytes support tumori-genesis and metastasis[J]. Biochim Biophys Acta,2013,1831(10):1533-1541.
  • 4Upton PD,Davies RJ, Trembath RC, et al. Bonemorphogenetic protein (BMP) and activin typeII receptors balance BMP9 signals mediatedby activin receptor-like kinase-1 in humanpulmonary artery endothelial cells[J].J Biol Chem,2009,284(23):15794-15804.
  • 5Boer K. Current trends in pharmacotherapyof breast cancer[J]. Orv Hetll,2002,143(14):725-730.
  • 6Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activatedphenotype and contribute to breast cancerinvasion[J]. Cancer Res,2011,71(7):2455-2465.
  • 7Wang YY, Lehu DC, Laurent V, et al. Adiposetissue and breast epithelial cells: a dangerousdynamic duo in breast cancer[J]. Cancer Lett,2012,324(2):142-151.
  • 8Chamras H1 Bagga D,Elstner E, et al.Preadipocytes stimulate breast cancer cellgrowth[J]. Nutr Cancer,1998,52(2):59-63.
  • 9Chandler EM, Seo BR, Califano JP, et al. Implantedadipose progenitor cells as physicochemicalregulators of breast cancer[J]. Proc Natl Acad SciUSA,2012,109(25):9786-9791.
  • 10Tseng YH,Kokkotou E, Schulz TJ, et al. Newrole of bone morphogenetic protein 7 in brownadipogenesis and energy expenditure[J]. Nature,2008,454(7207):1000-1004.

二级参考文献21

  • 1ALARMO E L, KALLIONIEMI A. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? [J]. Endocr Relat cancer, 2010, 17(2):R123-139.
  • 2BUIJS J T, QUE I, L( WlK C W, eta/. Inhibition of bone resorption and growth of breast cancer in the bone microenvironmentU]. Bone, 2009, 44(2):380-386. BOI R K. Current trends in pharmacotherapy of breast cancer[J]. Orv Hetil, 2002, 143(14):725-730.
  • 3KLOPP A H, LACERDA L, GUPTA A, et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells[J]. PLoS One, 2010, 5(8):el 2180.
  • 4HERRERA B, VAN DINTHER M, TEN DIJKE P, et al. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smadl/Smad4 to promote ovarian cancer cell proliferation[J]. Cancer Res, 2009, 69(24):9254-9262.
  • 5YE L, KYNASTON H, JIANG W G. Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway[J]. J Urol, 2009, 181 (6):2749-2759.
  • 6ITOH S, TEN DUKE P. Negative regulation of TGF- beta receptor/Smad signal transduction[J]. Curt Opin CellBiol, 2007, 1 9(2):1 76-1 84.
  • 7YANG S, DU J, WANG Z, et al. Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer[J]. IntJ Biochem Cell Biol, 2009, 41 (4):853-861.
  • 8SCHWALBE M, S ,NGER J, EGGERS R, et al. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer[J]. IntJ Oncol, 2003, 23(1):89-95.
  • 9HAKKI S S, FOSTER B L, NAGATOMO K J, et al. Bone morphogenetic protein-7 enhances cementoblast function in vitro[J]. J Periodontol, 2010, 81(11):1663-1674.
  • 10SCHWALBE M, S ,NGER J, EGGERS R, et al. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer[J]. IntJ Oncol, 2003, 23(1):89-95.

共引文献4

同被引文献14

  • 1Alarmo E.L., and Kallioniemi A., 2010, Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis, En- docr. Relat. Cancer, 17(2): R123-R139.
  • 2Davis A.A., and Kaklamani V.G., 2012, Metabolic syndrome and triple-negative breast cancer: a new paradigm, Int. J. Breast Cancer, 2012(809291): 1-10.
  • 3Fuentes-Mattei E., Velazquez-Torres G., Phan L., Zhang F., Chou P.C., Shin J.H., Choi H.H., Chen J.S., Zhao R., Chen J., Gully C., Carlock C., Qi Y., Zhang Y., Wu Y., Esteva F.J., Luo Y., McKeehan W.L., Ensor J., Hortobagyi G.N., Pusztai L., Fraser Symmans W., Lee M.H., and Yeung S.C., 2014, Effects of Obesity ontranscriptomic changes and cancer hall- marks in estrogen receptor-positive breast cancer, J. Natl. Cancer Inst., 106(7): 766-776.
  • 4Giordano C., Chemi F., Panza S., Barone I., Bonofiglio D., Lanzino M., Cordella A., Campana A., Hashim A., Rizza P., Leggio A., Gyorffy B., Simes B.M., Clarke R.B., Weisz A., Catalano S., and And S., 2016, Leptin as a mediator of tu- mor-stromal interactions promotes breast cancer stem cell activity, Oncotarget., 7(2): 1262-1275.
  • 5Kessenbrock K., Plaks V., and Werb Z., 2010, Matrix metallo- proteinases: Regulators of the tumor microenvironment, Cell, 141(1): 52-67.
  • 6Lee Y., Jung W.H., and Koo J.S., 2015, Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells, Breast Cancer Res. Treat., 153(2): 323-335.
  • 7Martin-Padura I., Gregato G., Marighetti P., Mancuso P., Calleri A., Corsini C., Pruneri G., Manzotti M., Lohsiriwat V., Riet- jens M., Petit J.Y., and Bertolini F., 2012, The white adiposetissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression, Ca- ncer Res., 72(1): 325-334.
  • 8Nieman K.M., Kenny H.A., Penicka C.V., Ladanyi A., Buell-Gutbrod R., Zillhardt M.R., Romero I.L., Carey M.S., Mills G.B., Hotamisligil G.S., Yamada S.D., Peter M.E., Gwin K., and Lengyel E., 2011, Adipocytes promote ovari- an cancer metastasis and provide energy for rapid tumor growth, Nat. Med., 17(11): 1498-503.
  • 9Nieman K.M., Romero I.L., Van Houten B., and Lengyel E., 2013, Adipose tissue and adipocytes support tumorigenesis and metastasis, Biochim. Biophys. Acta, 1831(10): 1533-1541.
  • 10Oh S.W., Park C.Y., Lee E.S., Yoon Y.S., Lee E.S., Park S.S., Kim Y., Sung N.J., Yun Y.H., Lee K.S., Kang H.S., Kwon Y., and Ro J., 2011, Adipokines, insulin resistance, metabol- ic syndrome, and breast cancer recurrence: a cohort study, Breast Cancer Res., 13(2): R34.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部